Cargando…
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society
This position statement from the Heart Failure Association of the European Society of Cardiology Cardio-Oncology Study Group in collaboration with the International Cardio-Oncology Society presents practical, easy-to-use and evidence-based risk stratification tools for oncologists, haemato-oncologis...
Ejemplares similares
-
Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
por: Lenihan, Daniel J., et al.
Publicado: (2019) -
Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’
por: Anker, Markus S., et al.
Publicado: (2019) -
Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020) -
The Establishment of the Nordic Cardio-Oncology Society
por: Broberg, Agneta Månsson, et al.
Publicado: (2020) -
Cardio-Oncology in Israel: Development and Future
por: Iakobishvili, Zaza, et al.
Publicado: (2019)